THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death — THALES

Acute Ischaemic Stroke Clinical Trial

Official title:
A Randomised, Double-Blind, Placebo-Controlled, International, Multicentre, Phase III Study to Investigate the Efficacy and Safety of Ticagrelor and ASA Compared With ASA in the Prevention of Stroke and Death in Patients With Acute Ischaemic Stroke or Transient Ischaemic Attack

Status Completed

Clinical Trial Summary

Study to investigate if the study drug ticagrelor and ASA is more effective than Placebo (inactive tablet) and ASA in preventing new stroke events

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03354429
Study type	Interventional
Source	AstraZeneca
Contact
Status	Completed
Phase	Phase 3
Start date	January 22, 2018
Completion date	December 13, 2019

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03463551` - Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic	Phase 2
Completed	`NCT02164357` - Efficacy and Security of an Endovascular Treatment as First Choice Procedure Compared With a Standard Intravenous Thrombolytic Therapy Treatment for Patients With Acute Ischemic Stroke Within 4.5 Hours After Onset	N/A
Recruiting	`NCT01207336` - Combined tDCS+PNS After Acute Stroke	Phase 2/Phase 3
Completed	`NCT03328403` - Endovascular Therapy in Acute Ischaemic Stroke Due to Large Vessel Occlusion	N/A
Recruiting	`NCT06379464` - Screening of New Markers of Gut Microbiota in Stroke and Depression: a Cross-sectional Study
Completed	`NCT03971526` - Magnetic Resonance Post-contrast Vascular Hyperintensities at 3 T: a Sensitive Sign of Vascular Occlusion in Acute Ischaemic Stroke
Recruiting	`NCT03639922` - Imatinib in Acute Ischaemic Stroke	Phase 3
Completed	`NCT03865225` - Effects of Heart Rate Variability Biofeedback in Patients With Acute Ischemic Stroke	N/A
Completed	`NCT03541668` - Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)	Phase 3
Completed	`NCT01994720` - [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]	Phase 3
Terminated	`NCT01745692` - Pragmatic Ischaemic Stroke Thrombectomy Evaluation	N/A
Completed	`NCT03578822` - Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial	Phase 3